Diminazen Aceturate Protects Pulmonary Ischemia-Reperfusion Injury via Inhibition of ADAM17-Mediated Angiotensin-Converting Enzyme 2 Shedding.

Front Pharmacol · 2021 · PMC8546118 · PMID 34712133

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

IR group, p < 0.05 ) and a decreasing trend of p38MAPK expression, however, without a statistical difference (level of p38MAPK IR + DIZE vs.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.